Medius Associates
Medius provides an unrivalled range of specialised business development training solutions to cater for all levels of learning. This range extends from client specific in house tutorials through open enrolment courses to the Pharmaceutical Licensing Group’s distance learning modular MSc course.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Amiculum
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Company Details
Latest Content from PMHub
Navigating Stress: Understanding, Addressing, and Supporting Our Team
White Papers and Resources | April 17, 2024 | Mednet
Explore how we're supporting our team with managing stress in the workplace
Research conducted for Johnson and Johnson published in scientific journal
Press Releases | April 17, 2024 | Inizio
Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.
Why choose a B Corp agency?
Press Releases | April 16, 2024 | Wallace Health
Going through the B Corp process – and successfully gaining certification at the end of last year – gave us a stronger sense of our values as an agency. It...
Getting Past the Old-Fashioned View of Patient Advocacy
Press Releases | April 16, 2024 | Medscape Education
Patient advocacy organizations today are data-driven, doing amazing work — and have the hard evidence to support their impact on patient care. The challenge is getting past the perception of...
Connecting our Inizio Advisory capabilities to help a client address a threat to the brand, guide strategy and improve brand performance
Press Releases | April 15, 2024 | Inizio
The challenge Our client knew that prescribing of a key brand in a major market had slowed and needed to understand which patient segments were impacted so they could address...
Enhancing Honesty in Feedback: Blinded Questions
Videos and Podcasts | April 11, 2024 | Impetus Digital
Explore our third tip in our series aimed at refining asynchronous virtual meetings. Discover how using blinded questions can significantly minimize bias and enhance the integrity of feedback in virtual...
Autoimmune conditions: Living With syndicated patient reports
White Papers and Resources | April 11, 2024 | Inizio
The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective management and care. In our...
Mile High Impact at AAN 2024
Press Releases | April 11, 2024 | Medscape Education
The Medscape team will be joining our neurology colleagues in Denver, CO for this year’s AAN Annual Meeting. Impact will take center stage at this year’s event as Medscape presents...
Everything Was Peachy at ACC 2024 in Atlanta, GA
Press Releases | April 10, 2024 | Medscape Education
The annual ACC meeting has officially wrapped up in Atlanta, bringing a successful conference to a close for another year. During the conference, members of the Medscape team hosted a...
What role does ICER play in US market access?
White Papers and Resources | April 9, 2024 | Petauri Evidence
The Institute for Clinical and Economic Review (ICER) is becoming an increasingly important player in US market access. As more transformative, but costly, treatments come to market, payers must continue...